Skip to main content

Month: August 2023

Peapack Private Hires James McKenna, Senior Managing Director, Commercial Private Banker

Peapack-GladstoneJames McKenna, Senior Managing Director, Commercial Private BankerBEDMINSTER, NJ, Aug. 30, 2023 (GLOBE NEWSWIRE) — via NewMediaWire  – Peapack-Gladstone Financial Corporation (NASDAQ Global Select Market: PGC) and Peapack Private, a division of Peapack-Gladstone Bank, announce the appointment of James McKenna as Senior Managing Director, Commercial Private Banker.  As the Bank expands its footprint into New York City, Mr. McKenna joins a team of seasoned and highly skilled commercial bankers whose primary focus is to build the Company’s presence with its core competencies across commercial banking, investment banking and wealth management. With more than 19 years of commercial lending expertise, McKenna previously served as First Vice President, Relationship Manager, at Valley National Bank (formerly Leumi...

Continue reading

Macerich’s Current Redevelopment at Scottsdale Fashion Square Progresses with More Retail Space for Men, More Dining

Men’s Luxury at Scottsdale Fashion Square Continues to Deliver Remarkable Success with Standalone Gucci and Louis Vuitton Men’s Stores DIOR, Salvatore Ferragamo, Christian Louboutin and Others Now DedicateMore Shop Space to Men A Media Snippet accompanying this announcement is available by clicking on the image or link below:SANTA MONICA, Calif., Aug. 30, 2023 (GLOBE NEWSWIRE) — Macerich (NYSE: MAC), one of the nation’s leading owners, operators and developers of high-quality retail and mixed-use properties in top markets, today detailed progress for its current redevelopment of the south wing at Scottsdale Fashion Square, including more experiential dining and more retail space dedicated exclusively to men. During Macerich’s Q2 2023 earnings call with analysts, Macerich Senior Executive Vice President of Leasing Doug Healey...

Continue reading

Decisions adopted in the Extraordinary General Meeting of Shareholders of LITGRID AB

The following decisions were adopted in the Extraordinary General Meeting of Shareholders of LITGRID AB (company code 302564383, registered address at Karlo Gustavo Emilio Manerheimo st. 8, LT-05131, Vilnius) on 30 August 2023: 1) Election of the audit company of LITGRID AB and determination of the terms of payment for audit services for the period of 2023-2025 1.1. UAB PricewaterhouseCoopers, company code 111473315 has been elected as the audit company that will perform the audit of the financial statements of LITGRID AB prepared in accordance with the International Financial Reporting Standards adopted in the European Union for the period of 2023-2025; 1.2. To set a remuneration of no more than 482,300 euros (excluding VAT) (including the cost of the audit of interim financial statements of 160,800 euros) for the audit services referred...

Continue reading

Plug Power Announces Settlement with SEC

LATHAM, N.Y., Aug. 30, 2023 (GLOBE NEWSWIRE) — Plug Power Inc. (NASDAQ:PLUG), a global leader in comprehensive hydrogen solutions for the green hydrogen economy, today announced the settlement of a civil administrative proceeding with the U.S. Securities and Exchange Commission (“SEC” or “Commission”) related to the Company’s March 16, 2021 announcement that the financial statements in its prior annual reports on Form 10-K for 2018 and 2019, and quarterly reports on Form 10-Q for 2019 and 2020, should no longer be relied upon. On May 14, 2021, the Company filed a Form 10-K for 2020 that included restated financial statements for those periods. The Company, without admitting or denying the findings, agreed to a cease-and-desist order regarding Sections 13(a), 13(b)(2)(A), and 13(b)(2)(B) of the Securities Exchange Act, and Rules...

Continue reading

Delårsrapport för perioden 1 januari 2023 – 30 juni 2023, Svensk Hypotekspension Fond 4 AB (publ)

Stockholm, 30 augusti 2023 Delårsrapport för perioden 1 januari 2023 – 30 juni 2023, Svensk Hypotekspension Fond 4 AB (publ) Delårsrapporten biläggs. Den finns också tillgänglig på bolagets hemsida www.shpfond4.se. För ytterligare information, vänligen kontakta:Anders Larsson, VD på Svensk Hypotekspension AB 08-586 160 11 anders.larsson@hypotekspension.seViktig informationInformationen lämnades, genom ovanstående kontaktpersons försorg, för offentliggörande den 30 augusti 2023 kl. 15:00.AttachmentSvensk Hypotekspension Fond 4 AB (publ) – Delårsrapport – 230630

Continue reading

Global Ultra High Molecular Weight Polyethylene Market Size to Reach USD 4.32 Billion in 2032 | Emergen Research

Growing requirements from aerospace & defense industry is a major factor driving global ultra high molecular weight polyethylene market revenue growth Vancouver, Aug. 30, 2023 (GLOBE NEWSWIRE) — The projected size of the global ultra high molecular weight polyethylene market is anticipated to achieve USD 4.32 Billion by 2032, with a registered annual revenue compound growth rate (CAGR) of 9.1% throughout the forecast period, as stated in the most recent analysis conducted by Emergen Research. The gradual expansion of market revenue can be attributed to the increasing utilization of ultra high molecular weight polyethylene in orthopedic implant applications. Notably, Ultra-High Molecular Weight Polyethylene (UHMWPE) finds extensive application in orthopedic implants, particularly for surfaces experiencing elevated stress levels,...

Continue reading

Hovnanian Enterprises Reports Fiscal 2023 Third Quarter Results

81% Year over Year Increase in Net ContractsNet Contracts per Community Increased 92% Year over YearHomebuilding Gross Margin Percentage Improved Sequentially by 230 Basis Points53% Sequential Growth in Income Before Income TaxesRedeemed in August $100 Million of Principal Amount of 7.75% Senior Secured Notes Due February 2026Increased Full Year Guidance MATAWAN, N.J., Aug. 30, 2023 (GLOBE NEWSWIRE) — Hovnanian Enterprises, Inc. (NYSE: HOV), a leading national homebuilder, reported results for its fiscal third quarter and nine months ended July 31, 2023. RESULTS FOR THE THREE-MONTH AND NINE-MONTH PERIODS ENDED JULY 31, 2023:Total revenues were $650.0 million (including 1,198 homes) in the third quarter of fiscal 2023, compared with $767.6 million (including 1,412 homes) in the same quarter of the prior year. For the nine months...

Continue reading

CEMATRIX Announces a $10.7 Million Increase in Contracts

Backlog Grows to $107.7 Million CALGARY, Alberta, Aug. 30, 2023 (GLOBE NEWSWIRE) — CEMATRIX Corporation (TSXV: CVX) (OTCQB: CTXXF) (“CEMATRIX” or the “Company“) a North American leading manufacturer and supplier of technologically advanced cellular concrete products is pleased to announce its 2023 Contracts have increased by $10.7 million bringing its total contracts announced since the end of the fiscal 2022 year to $37.9 million and $74.9 million since August 3, 2022. Over $40 million of the current backlog is scheduled for 2023, a 37.9% increase compared to total sales of $29 million for the fiscal 2022 year. The $40 million in scheduled 2023 backlog is contracted and a portion of these contracts have already been placed in 2023. The Corporation’s backlog, which is net of sales to the end of July, has...

Continue reading

Sofwave Medical Announces FDA Clearance of SUPERB™ Technology For Treatment of Acne Scars

FDA clearance supported by a clinical study (n=67) and demonstrated treatment safety and efficacy utilizing SUPERB™, 97% of the treated participants in the trial showed improvement in the appearance of acne scars as assessed by masked evaluations Global market value of acne scarring treatment market is expected to cross $4.9 billion by 2029(1)SAN CLEMENTE, Calif. , Aug. 30, 2023 (GLOBE NEWSWIRE) — Sofwave Medical Ltd (“the Company”) (TASE: SOFW), an emerging leader in energy-based non-invasive, aesthetic medical devices for practitioners worldwide, announced clearance by the U.S. Food and Drug Administration (FDA) for the Company’s 510(k) premarket notification submission to market SUPERB™ for the treatment of acne scars. The approval clears the way for Sofwave™ to expand treatment indication of the Company’s...

Continue reading

Veru to Present at the H.C. Wainwright 25th Annual Global Investment Conference on September 11th, 2023

MIAMI, Aug. 30, 2023 (GLOBE NEWSWIRE) — Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing novel medicines for metastatic breast cancer and for viral induced acute respiratory distress syndrome (ARDS), today announced that Mitchell Steiner, M.D., Chairman, President and Chief Executive Officer of Veru, will present at the H.C. Wainwright 25th Annual Global Investment Conference to be held at the Lotte New York Palace Hotel in New York City on Monday, September 11th, 2023 at 9:00 a.m. ET. A live webcast will be accessible through the Investors section of the Company’s website at www.verupharma.com. Following the event, an archived webcast will be available on the Veru website. About Veru Inc.Veru is a late clinical stage biopharmaceutical company focused on developing novel medicines...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.